Company filings profile · CIK 0001716947
Ensysce Biosciences, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Ensysce Biosciences, Inc. (ENSC): 12 filings in the last 90 days vs 12 in the prior 90 (filing-velocity steady · 1×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 30, 2026. Source-linked, daily-refreshed.
Material 8-K events — Ensysce Biosciences, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 29, 2026 | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Aug 25, 2026 | Other Events | ↗ |
| Aug 24, 2026 | Other Events | ↗ |
| Aug 13, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 6, 2026 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Item 3.03; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 15, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| May 22, 2026 | Delisting / Listing-Rule Failure | ↗ |
| May 15, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 8, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 3, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Mar 23, 2026 | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Feb 27, 2026 | Delisting / Listing-Rule Failure | ↗ |
| Jan 8, 2026 | Item 5.07 | ↗ |
Watch Ensysce Biosciences, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 29, 2026 | 8-K | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Aug 25, 2026 | 8-K | Other Events | ↗ |
| Aug 24, 2026 | 8-K | Other Events | ↗ |
| Aug 20, 2026 | D | Item 06b | ↗ |
| Aug 18, 2026 | SCHEDULE 13D/A | ↗ | |
| Aug 18, 2026 | 4 | 4 | ↗ |
| Aug 13, 2026 | 10-Q | 10-Q | ↗ |
| Aug 13, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 10, 2026 | 3 | 3 | ↗ |
| Aug 6, 2026 | 8-K/A | Financial Statements and Exhibits | ↗ |
| Aug 6, 2026 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Item 3.03; Departure/Election of Directors or Officers; Amendments to Bylaws/Charter; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 15, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jun 26, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Jun 4, 2026 | S-3 | S-3 | ↗ |
| May 22, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| May 15, 2026 | 10-Q | 10-Q | ↗ |
| May 15, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 30, 2026 | S-8 | S-8 | ↗ |
| Apr 15, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| Apr 14, 2026 | CORRESP | ↗ | |
| Apr 13, 2026 | UPLOAD | ↗ | |
| Apr 9, 2026 | S-3 | S-3 | ↗ |
| Apr 8, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 3, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | 10-K | 10-K | ↗ |
| Mar 30, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Mar 23, 2026 | 8-K | Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Feb 27, 2026 | 8-K | Delisting / Listing-Rule Failure | ↗ |
| Jan 8, 2026 | 8-K | Item 5.07 | ↗ |
| Dec 16, 2025 | DEFA14A | DEFA14A | ↗ |
| Dec 11, 2025 | EFFECT | Item ; Item ; Item | ↗ |
| Dec 9, 2025 | CORRESP | ↗ | |
| Dec 2, 2025 | S-3 | S-3 | ↗ |
| Dec 2, 2025 | ARS | ARS | ↗ |
| Dec 2, 2025 | DEF 14A | DEF 14A | ↗ |
| Nov 21, 2025 | PRE 14A | PRE 14A | ↗ |
| Nov 17, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Amendments to Bylaws/Charter; Other Events; Financial Statements and Exhibits | ↗ |
| Nov 14, 2025 | 10-Q | 10-Q | ↗ |
| Nov 14, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |